Table 1.

Effect of IL-18 on the percent of splenic cellular phenotype

GroupTotal cells%CD4+%CD8+% B220+%Gr-1+
Diluent 110.4 ± 7.8 × 106 24% ± 5% 13% ± 3% 51% ± 9% 2.5% ± 0.6% 
IL-18 179.8 ± 12 × 106* 19% ± 6% 9% ± 3.8% 46% ± 14% 13.4% ± 1.27%* 
GroupTotal cells%CD4+%CD8+% B220+%Gr-1+
Diluent 110.4 ± 7.8 × 106 24% ± 5% 13% ± 3% 51% ± 9% 2.5% ± 0.6% 
IL-18 179.8 ± 12 × 106* 19% ± 6% 9% ± 3.8% 46% ± 14% 13.4% ± 1.27%* 

BALB/c mice (n = 3/group) were injected with 1 μg/day of IL-18 or the diluent (control) for 10 days. Splenocytes were harvested on day 11 and analyzed for cellular phenotype by 2-colored flow cytometry. IL-18 treatment increased the total number of cells and the percent of Gr-1 cells (

*

P < .03) but did not significantly alter the ratios of CD4+, CD8+, or B220+ cells.

Close Modal

or Create an Account

Close Modal
Close Modal